| Jan 19, 2017 |
PRINCETON, N.J., Jan. 19, 2017 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company, announced today that its Chief Executive Officer, Al Altomari will present at Noble Capital Markets' Thirteenth Annual Investor/ Equity Conference on Tuesday, January 31, 2017 at 11:00 am E...
|
|
| Jan 3, 2017 |
Resubmission of Twirla® New Drug Application Expected to Address FDA's Complete Response LetterCompany Plans to Resubmit NDA in First Half of 2017 Company to Host Conference Call on January 3, 2017 at 5:00 p.m...
|
|
| Dec 22, 2016 |
PRINCETON, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) announced today that its Chief Executive Officer, Al Altomari will present at the Biotech Showcase 2017 on Monday, January 9, 2017 at 9:00 AM Pacific Time. The conference will be held at the Hilton San Francisco Union Square....
|
|
| Dec 22, 2016 |
PRINCETON, N.J., Dec. 22, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX) a women's health specialty pharmaceutical company, announced today that its Chief Executive Officer, Al Altomari will present at the 35th Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2017 at 11:30 AM Pacific Time. ...
|
|
| Dec 1, 2016 |
PRINCETON, N.J., Dec. 01, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company announced today that it has received net proceeds of approximately $3 million in non-dilutive financing through the State of New Jersey's Technology Business Tax Certificate Transfer Pro...
|
|
| Nov 7, 2016 |
Top-Line Data Expected in Early January 2017; Resubmission Planned for First Half 2017 Cash Expected to Fund Operations Through the End of 2017 PRINCETON, N.J., Nov. 07, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a wom...
|
|
| Aug 8, 2016 |
PRINCETON, N.J., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today reported financial results for the three and six months ended June 30, 2016 and provide...
|
|
| Jul 28, 2016 |
PRINCETON, N.J., July 28, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) today announced the appointment of Seth H. Z. Fischer to the Company's Board of Directors, effective July 28, 2016. Mr. Fischer will serve on Agile's Compensation and Nominating & Corporate Governance Committees. ...
|
|
| Jul 12, 2016 |
PRINCETON, N.J., July 12, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that preparations are underway for an initial Phase 2 clinical trial of a novel ...
|
|
| Jul 6, 2016 |
PRINCETON, N.J., July 06, 2016 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (NASDAQ:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that it had strengthened its executive leadership team with the appointment ...
|
|